Tocilizumab for COVID-19: a real 'miracle drug'?

被引：1
|
作者：
Nasim, Sundus [1 ]
Hashmi, Shariq Haider [2 ]
Azim, Dua [1 ]
Kumar, Sohail [1 ]
Nasim, Jasia [1 ]
机构：
[1] Dow Univ Hlth Sci, Dow Med Coll, Karachi, Pakistan
[2] NYU, Grossman Sch Med, New York, NY USA
来源：
INFECTIOUS DISEASES | 2020年 / 52卷 / 09期
关键词：
D O I：
10.1080/23744235.2020.1780307
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：681 / 682
页数：2
相关论文
共 50 条
  • [31] Tocilizumab in COVID-19: Is the Temptation Worthwhile?
    Gupta, Sachin
    Tomar, Deeksha S.
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2021, 25 (03) : 247 - 248
  • [32] Tocilizumab therapy in COVID-19 patients
    Yulistiani
    Izka, Humaira A.
    Rindang, Mareta A.
    Prastuti, A. W.
    PHARMACY EDUCATION, 2022, 22 (02): : 259 - 262
  • [33] COVID-19: Still a place for tocilizumab?
    Richier, Q.
    Placais, L.
    Lacombe, K.
    Hermine, O.
    REVUE DE MEDECINE INTERNE, 2021, 42 (02): : 73 - 78
  • [34] Real-Life Use of Tocilizumab in the Treatment of Severe COVID-19 Pneumonia
    Alex, Ruth
    Gulam, Shabaz Mohiuddin
    Kumar, Kiran
    ADVANCES IN VIROLOGY, 2022, 2022
  • [35] Real-life prospective study on tocilizumab in severe COVID-19 infection
    Power, L.
    Morarasu, B.
    Sarfaraz, A.
    Basirat, A.
    Rahman, H.
    Donnelly, S.
    Moloney, E.
    Kooblall, M.
    Lane, S.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [36] Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database
    Charan, Jaykaran
    Dutta, Siddhartha
    Kaur, Rimplejeet
    Bhardwaj, Pankaj
    Sharma, Praveen
    Ambwani, Sneha
    Jahan, Iffat
    Abubakar, Abdullahi Rabiu
    Islam, Salequl
    Hardcastle, Timothy Craig
    Rahman, Nor
    Lugova, Halyna
    Haque, Mainul
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (09) : 1125 - 1136
  • [37] Systematic Review on Treatment Trials of Tocilizumab: A Repurposing Drug against COVID-19
    Banerjee, Shilpita
    Mahapatra, Ajit Kumar
    REVIEWS ON RECENT CLINICAL TRIALS, 2021, 16 (04) : 381 - 389
  • [38] Repurposed Tocilizumab in Patients with Severe COVID-19
    Tian, Jianbo
    Zhang, Ming
    Jin, Meng
    Zhang, Fengqin
    Chu, Qian
    Wang, Xiaoyang
    Chen, Can
    Yue, Huihui
    Zhang, Li
    Du, Ronghui
    Zhao, Dong
    Zeng, Zhaofu
    Zhao, Yang
    Liu, Kui
    Wang, Mengmei
    Hu, Ke
    Miao, Xiaoping
    Zhang, Huilan
    JOURNAL OF IMMUNOLOGY, 2021, 206 (03): : 599 - 606
  • [39] Tocilizumab and COVID-19: Timing of Administration and Efficacy
    Abidi, Emna
    El Nekidy, Wasim S.
    Alefishat, Eman
    Rahman, Nadeem
    Petroianu, Georg A.
    El-Lababidi, Rania
    Mallat, Jihad
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [40] BRADYCARDIA FOLLOWING TOCILIZUMAB ADMINISTRATION FOR COVID-19
    Staubs, Amanda
    Noori, Feroz
    Houshmand, Farnaz
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 69 - 69
12345